3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Current Status of Childhood Hyperinsulinemic Hypoglycemia in Turkey.
|
27181376 |
2016 |
Hyperinsulinemic Hypoglycemia, Familial, 4
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Current Status of Childhood Hyperinsulinemic Hypoglycemia in Turkey.
|
27181376 |
2016 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation.
|
23273570 |
2013 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Diagnosis of a patient with a kinetic variant of medium and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by newborn screening.
|
22579592 |
2012 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CLINGEN |
3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations.
|
23430856 |
2012 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the regulation of body weight and thermogenesis.
|
21990309 |
2011 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene.
|
15870679 |
2005 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.
|
11489939 |
2001 |
Hyperinsulinemic Hypoglycemia, Familial, 4
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.
|
11489939 |
2001 |
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
3-Hydroxyacyl-CoA Dehydrogenase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperinsulinemic Hypoglycemia, Familial, 4
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperinsulinemic Hypoglycemia, Familial, 4
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hyperinsulinemic Hypoglycemia, Familial, 4
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Obesity
|
0.510 |
Biomarker
|
disease |
BEFREE |
Two MTPα activities, 3-hydroxyacyl-CoA dehydrogenase and long-chain hydratase, have been linked with the occurrence and development of obesity and obesity-related disorders.
|
28552586 |
2017 |
Obesity
|
0.510 |
Biomarker
|
disease |
CTD_human |
Orchestrated downregulation of genes involved in oxidative metabolic pathways in obese vs. lean high-fat young male consumers.
|
20882379 |
2011 |
Obesity
|
0.510 |
Biomarker
|
disease |
RGD |
Different forms of obesity as a function of diet composition.
|
16088331 |
2005 |
Precancerous Conditions
|
0.300 |
Biomarker
|
group |
CTD_human |
Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS.
|
21472284 |
2012 |
Condition, Preneoplastic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS.
|
21472284 |
2012 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Hyperinsulinemic Hypoglycemia of Infancy due to Novel HADH Mutation in Two Siblings.
|
27771675 |
2016 |
Congenital Hyperinsulinism
|
0.200 |
Biomarker
|
disease |
BEFREE |
At a molecular level, genetic abnormalities in nine different genes (ABCC8, KCNJ11, GLUD1, GCK, HNF4A, HNF1A, SLC16A1, UCP2 and HADH) have been identified which cause CHI.
|
25733449 |
2015 |
Congenital Hyperinsulinism
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We present clinical and laboratory findings together with the long-term clinical course of a case with a deep intronic HADH splicing mutation (c.636+471G>T) causing neonatal-onset hyperinsulinemic hypoglycemia with mild progression.
|
26316438 |
2015 |